Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AK18
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 27 | 31 | PF00656 | 0.623 |
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.623 |
CLV_NRD_NRD_1 | 180 | 182 | PF00675 | 0.554 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.552 |
CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.424 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.521 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.579 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.424 |
CLV_PCSK_PC1ET2_1 | 105 | 107 | PF00082 | 0.484 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.564 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.579 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.465 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.569 |
CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.483 |
DOC_MAPK_gen_1 | 11 | 20 | PF00069 | 0.473 |
DOC_PP2B_LxvP_1 | 3 | 6 | PF13499 | 0.530 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.586 |
DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.501 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.678 |
LIG_BRCT_BRCA1_1 | 63 | 67 | PF00533 | 0.492 |
LIG_FHA_2 | 14 | 20 | PF00498 | 0.614 |
LIG_FHA_2 | 92 | 98 | PF00498 | 0.540 |
LIG_MAD2 | 163 | 171 | PF02301 | 0.578 |
LIG_Pex14_2 | 174 | 178 | PF04695 | 0.579 |
LIG_REV1ctd_RIR_1 | 172 | 181 | PF16727 | 0.573 |
LIG_SH2_STAP1 | 37 | 41 | PF00017 | 0.460 |
LIG_WRC_WIRS_1 | 80 | 85 | PF05994 | 0.459 |
MOD_CDK_SPK_2 | 123 | 128 | PF00069 | 0.693 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.606 |
MOD_CK2_1 | 163 | 169 | PF00069 | 0.546 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.524 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.444 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.698 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.563 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.651 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.503 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.556 |
MOD_PKA_1 | 91 | 97 | PF00069 | 0.549 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.495 |
MOD_PKB_1 | 152 | 160 | PF00069 | 0.671 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.680 |
TRG_ER_diArg_1 | 90 | 92 | PF00400 | 0.447 |
TRG_NLS_MonoCore_2 | 178 | 183 | PF00514 | 0.584 |
TRG_NLS_MonoExtC_3 | 178 | 184 | PF00514 | 0.582 |
TRG_NLS_MonoExtN_4 | 177 | 183 | PF00514 | 0.527 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PC96 | Leptomonas seymouri | 82% | 99% |
A0A0S4J1V1 | Bodo saltans | 54% | 98% |
A0A1X0NLC2 | Trypanosomatidae | 55% | 100% |
A0A3R7MRB1 | Trypanosoma rangeli | 58% | 88% |
A0A3S7WNN7 | Leishmania donovani | 92% | 100% |
A4HS31 | Leishmania infantum | 91% | 100% |
C9ZY23 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
Q9XZX5 | Leishmania major | 92% | 100% |